Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGD | P52209 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL987602 | 1.00 | PGD (0.37) | PGDLMNAALDH1A1OR51E2TDP1 | |
| SCHEMBL6686437 | 1.00 | PGD (0.37) | PGDLMNAALDH1A1OR51E2TDP1 | |
| SCHEMBL18902784 | 1.00 | PGD (0.37) | PGDLMNAALDH1A1OR51E2TDP1 | |
| SCHEMBL4445885 | 0.96 | PGD (0.36) | PGDLMNAALDH1A1OR51E2TDP1 | |
| SCHEMBL1000048 | 0.92 | PGD (0.37) | PGDLMNAALDH1A1OR51E2TDP1 | |
| SCHEMBL5063165 | 0.87 | TSHR (0.50) | PGDLMNAALDH1A1TSHRHIF1A | |
| SCHEMBL31134456 | 0.87 | TSHR (0.50) | PGDLMNAALDH1A1TSHRHIF1A | |
| SCHEMBL31482274 | 0.87 | TSHR (0.50) | PGDLMNAALDH1A1TSHRHIF1A | |
| SCHEMBL22388686 | 0.87 | TSHR (0.50) | PGDLMNAALDH1A1TSHRHIF1A | |
| SCHEMBL31028137 | 0.87 | TSHR (0.50) | PGDLMNAALDH1A1TSHRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025097180-A1 | BIOBASED COMPOUNDS FOR POLYMER PRODUCTION | SOLUGEN, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| US-20250084031-A1 | METHOD OF PREPARING GLUCOSE-DERIVED ADIPONITRILE AND A METHOD OF DEHYDRATING BIOMASS-DERIVED AMIDE COMPOUND | HYUNDAI MOTOR COMPANY (KR) | 2025-03-13 | — | — | US | claimed |
| US-20220306610-A1 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC. (US) | 2022-09-29 | — | — | US | claimed |
| CN-114133844-A | High-weather-resistance powder coating for metal guardrail and preparation method and application thereof | 苏亿护栏有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-111662423-A | Preparation method of hydroxyl functionalized waterborne polyurethane | 中国科学院山西煤炭化学研究所 | 2020-09-15 | — | — | CN | claimed |
| CN-101001615-B | Drug delivery product and method | NEXMED HOLDINGS INC | 2012-07-04 | — | — | CN | claimed |
| EP-3565808-B1 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | ARDELYX INC (US) | 2026-03-04 | — | — | EP | disclosed |
| WO-2025097180-A1 | BIOBASED COMPOUNDS FOR POLYMER PRODUCTION | SOLUGEN, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| US-12281103-B2 | Compounds useful for treating gastrointestinal tract disorders | ARDELYX, INC. (US) | 2025-04-22 | — | — | US | disclosed |
| US-20250084031-A1 | METHOD OF PREPARING GLUCOSE-DERIVED ADIPONITRILE AND A METHOD OF DEHYDRATING BIOMASS-DERIVED AMIDE COMPOUND | HYUNDAI MOTOR COMPANY (KR) | 2025-03-13 | — | — | US | disclosed |
| CN-114008065-B | Glycyrrhetinic acid derivatives for the treatment of hyperkalemia | 阿德利克斯股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| US-20250067907-A1 | COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA | ARDELYX, INC. (US) | 2025-02-27 | — | — | US | disclosed |
| US-20240317719-A1 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC. (US) | 2024-09-26 | — | — | US | disclosed |
| CN-114008065-A | Glycyrrhetinic acid derivatives for treating hyperkalemia | 阿德利克斯股份有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-111662423-A | Preparation method of hydroxyl functionalized waterborne polyurethane | 中国科学院山西煤炭化学研究所 | 2020-09-15 | — | — | CN | disclosed |
| CN-111132968-A | N-alkyl-D-glucaric acid-6-amide derivatives and alkylammonium salts thereof as intermediates for the preparation of D-glucaric acid-6, 3-lactone monoamide | 巴斯夫欧洲公司 | 2020-05-08 | — | — | CN | disclosed |
| EP-3565808-A1 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | Ardelyx, Inc. (US) | 2019-11-13 | — | — | EP | disclosed |
| WO-2018129552-A1 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC. (US) | 2018-07-12 | — | — | WO | disclosed |
| EP-2101220-A1 | Protective overcoat of photoreceptor having a charge transport compound | Xerox Corporation (US) | 2009-09-16 | — | — | EP | disclosed |
| US-20090214969-A1 | PROTECTIVE OVERCOAT OF PHOTORECEPTOR HAVING A CHARGE TRANSPORT COMPOUND | XEROX CORPORATION (US) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220306610-A1 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | SLC10A2, FABP2, SLC10A1 | PGD 920/4885LMNA 4122/4885ALDH1A1 1579/4885 |
| US-20250084031-A1 | METHOD OF PREPARING GLUCOSE-DERIVED ADIPONITRILE AND A METHOD OF DEHYDRATING BIOMASS-DERIVED AMIDE COMPOUND | SLC2A8, FABP4, SLC2A4 | PGD 38/4885LMNA 2034/4885ALDH1A1 1725/4885 |
| US-20250067907-A1 | COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA | REN, NHERF1, KCNJ11 | PGD 2223/4885LMNA 1098/4885ALDH1A1 1308/4885 |
| US-12281103-B2 | Compounds useful for treating gastrointestinal tract disorders | SLC10A2, FABP2, SLC10A1 | PGD 920/4885LMNA 4122/4885ALDH1A1 1579/4885 |
| US-20240317719-A1 | COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS | SLC10A2, FABP2, SLC10A1 | PGD 920/4885LMNA 4122/4885ALDH1A1 1579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.